Protection of anogenital warts conferred by HPV vaccination in immunocompetent girls

Population : Immunocompetent girls
Intervention: HPV vaccination
Comparison: Placebo/ no vaccination
Outcome : Anogenital warts
What is the scientific evidence to support administration of the currently licensed quadrivalent HPV vaccine* to immunocompetent girls to substantially reduce their risk of developing anogenital warts later in life?